Developing biological standards for vaccine evaluation-Reference-Cited by-同舟云学术

Developing biological standards for vaccine evaluation

Published:2017-08 Issue:8 Volume:12 Page:431-437
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Page Mark¹,Wilkinson Dianna E¹,Mattiuzzo Giada¹,Efstathiou Stacey¹,Minor Philip¹

Affiliation:

1. Division of Virology, National Institute for Biological Standards & Control, Blanche Lane, South Mimms, Potters Bar, Herfordshire, EN6 3QG, UK

Abstract

This perspective describes the process of producing biological reference standards, explains why they are needed, who should use them and in what situations. The aim of this perpective is to promote their use at an early stage of vaccine development and to make developers aware of the advantages in doing so.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2017-0003

Reference14 articles.

1. Wilkinson DE, Page M, Almond N Expert committee on biological standardization preliminary report WHO collaborative study to assess the suitability of interim standards for Ebola virus NAT assays. WHO, Geneva, Switzerland (2015).

2. WHO. WHO consultation on commutability of WHO biological reference preparations forin vitrodetection of infectious markers. Geneva, Switzerland, 21–25 October 2013.

3. Reproducibility of Serologic Assays for Influenza Virus A (H5N1)

4. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and sera;Molecular Pharmaceutics and Nano Drug Delivery;2024

2. Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature;Frontiers in Immunology;2023-09-18

3. Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects;Clinica Chimica Acta;2021-11

4. WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community;The Lancet Microbe;2021-10

5. RSV neutralization assays – Use in immune response assessment;Vaccine;2021-07